On April 30, TLA held its second annual awards event to honor those whose work directly affects the quality of life for people in Tucson, across Arizona and throughout the world through research, collaboration and innovation -- key elements in the University’s land-grant mission and Never Settle strategic plan.

Campylobacter jejuni infection causes 1.3 million illnesses and generates over $1B in healthcare costs in the U.S. each year. Tucson company Anivax has now licensed a revolutionary Campylobacter food safety vaccine collaboratively developed at the UA and ASU to address the problem.

This week Tech Launch Arizona took the lead and hosted a conference of experts in technology commercialization from across the country. "Commercialization by Design" drew the brightest minds in the field to share best practices at the intersection of innovation, entrepreneurship and economic growth.

An innovative app that incentivizes commuters to change their driving habits for improved regional traffic has officially hit the streets of Tucson.

UA startup company GlycoSurf has finalized an exclusive license agreement for a novel method for chemically synthesizing environmentally-friendly biosurfactants. These non-toxic, sugar-based chemicals are used in cosmetics and personal care products, as well as in oil spill cleanups. With new CEO Chett Boxley in place, the company stands ready to enter the marketplace.